Biventricular pacing;Scompenso cardiaco refrattario. La stimolazione multisito

Italian Heart Journal Supplement

Volumn 3, Issue 8, 2002, Pages 831-836

  Boccanelli, Alessandro ^a   Gaita, Fiorenzo ^b  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

Author keywords

Chronic heart failure; Dyssynchrony; Resynchronization therapy

Indexed keywords

ADRENERGIC ACTIVITY; ATRIOVENTRICULAR BLOCK; HEART ATRIUM FIBRILLATION; HEART DILATATION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE PACING; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; PROGNOSIS; QRS COMPLEX; QUALITY OF LIFE; REGISTER; REVIEW; ARTIFICIAL HEART PACEMAKER; CONGESTIVE HEART FAILURE;

HEART FAILURE, CONGESTIVE; HUMANS; PACEMAKER, ARTIFICIAL;

EID: 0242364193     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Shoeller R, Andresen D, Buttner P, Oezcelik K, Vey G, Schroder R. First- or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. Am J Cardiol 1993; 71: 720-6.
2. Wilensky RL, Yudelman P, Cohen AI, et al. Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy. Am J Cardiol 1988; 62: 276-83.
3. Kelly TL, Cremo R, Nielsen C, Shabetai R. Prediction of outcome in late stage cardiomyopathy. Am Heart J 1990; 119: 1111-21.
4. Shanim W, Francis D, Yousufuddin M, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999; 70: 171-8.
5. Xiao HB, Brecker SD, Gibson DG. Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy. Br Heart J 1992; 68: 403-7.
6. Massie BM. Fifteen years of heart-failure trials: what have we learned? Lancet 1998; 352 (Suppl 1): SI29-SI33.
7. Hochleitner M, Hortnagi H, Ng CK, Gschnitzer F, Zechmann W. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 66: 198-202.
8. Linde C, Gadler F, Edner M, Nordlander R, Rosenqvist M. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995; 75: 919-23.
9. Buckingham TA, Candinas R, Schlapfer J, et al. Acute hemodynamic effects of atrioventricular pacing at differing sites in the right ventricle individually and simultaneously. Pacing Clin Electrophysiol 1997; 20: 909-15.
10. Brecker SJD, Gibson DG. What is the role of pacing in dilated cardiomyopathy? Eur Heart J 1996; 17: 819-24.
11. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999; 99: 1567-73.
12. Aloiso C, Leclercq C, Victor C, et al. Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am J Cardiol 1999; 84: 1417-21.
13. Xiao HB, Roy C, Gibson DG. Nature of ventricular activation in patients with dilated cardiomyopathy. Evidence for bilateral bundle branch block. Br Heart J 1994; 72: 167-74.
14. Bakker PF, Meijburg H, De Jourge N, et al. Beneficial effects of biventricular pacing in congestive heart failure. (abstr) Pacing Clin Electrophysiol 1994; 17: 820.
15. Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994; 17 (Part 2): 1974-9.
16. Ritter P, Cazean S, Mundler O, et al. Modifications of ventricular activation sequences during biventricular pacing in end-stage congestive heart failure. (abstr) European Journal of Cardiac Pacing and Electrophysiology 1996; 6: 139.
17. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999; 99: 2993-3001.
18. Leclercq C, Cazeau S, Le Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998; 32: 1825-31.
19. Auricchio A, Stellbrink C, Sack S, et al, on behalf of the PATH-CHF Study Group. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) Study: rationale, design and endpoints of a prospective randomized multicenter study. Am J Cardiol 1999; 83: 130D-135D.
20. Zardini M, Tritto M, Salerno JA, et al. The InSync Italian Registry: analysis of clinical outcome and considerations on the selection of candidates to left ventricular resynchronization. Eur Heart J Suppl 2000; 2 (Suppl J): J16-J22.
21. Etienne Y, Mansourati J, Gilard M, et al. Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation. Am J Cardiol 1999; 83: 1138-40.
22. Leclercq C, Alonso C, Victor F, et al. Long-term results of permanent biventricular pacing in patients with advanced heart failure: comparison of patients with stable sinus rhythm and chronic atrial fibrillation. (abstr) Pacing Clin Electrophysiol 2000; 23: 635.
23. Saxon LA, Boehmer JP, Hummel J, et al, for the VIGOR CHF and VENTAK CHF Investigators. Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. Am J Cardiol 1999; 833: 120D-123D.
24. Stellbrink C, Auricchio A, Butter C, et al. Pacing therapies in congestive heart failure II study. Am J Cardiol 2000; 86 (Suppl 1): K138-K143.
25. Cazeau S, Leclercq C, Lavergue T, et al, for the Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-80.
26. Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail 2000; 4: 369-80.
27. PACMAN. Rationale and design. Eur Heart J 2002, in press.
28. Thackray S, Coletta A, Jones P, Dunn A, Clark AL, Cleland JG. Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur J Heart Fail 2001; 3: 491-4.
29. Cleland JG, Daubert JC, Erdmann E, et al, on behalf of the CARE-HF Study Steering Committee and Investigators. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail 2001; 3: 481-9.
30. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) Trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail 2001; 6: 276-85.
31. Bardy GH, Mark DB, et al, for the SCD-HeFT Pilot Investigators. SCD-HeFT Interim publication of results. (abstr) Pacing Clin Electrophysiol 1997; 20 (II): 1148.
32. Remme WJ, Swedberg W, for the Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-60.